Paolo Massirio
Datos Biográficos
| ID | 7630376 |
|---|---|
| NOMBRE | Paolo Massirio |
| NOMBRES | Paolo |
| APELLIDO | Massirio |
| FIRMA | MASSIRIO P |
| AFILIACIONES | Istituto Giannina Gaslini |
| ORCID | 0000-0002-2367-4839 |
| VERIFICADO | Sí |
| TOTAL DE OBRAS | 2 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 2 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2024 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2025 |
| ÍNDICE H | 0 |
Second Attempt for Patent Ductus Arteriosus (PDA) Closure
Background : The diagnosis of hemodynamically significant patent ductus arteriosus (hsPDA) occurs in 55% of very low birth weight (VLBW) preterm infants. There is no agreement on the best approach to ensure a quick hsPDA closure. Drug treatment of hsPDA fails in approximately 20% of cases with an increasing risk of prolonged ventilation, BPD, and NEC, as well as the need for surgical duct ligation. This study aims to highlight the efficacy of ibu…
Do Different Amounts of Exogenous Surfactant Differently Influence Cerebrovascular Instability in a Consecutive Group of Preterm Babies? Preliminary Results from a Single-Center Experience
Our data obtained from the group with > 3 fractionated doses of ES seem to justify the preparation of a more robust study, as the combination of reduced NIRS variability and reduced tCO 2 maximum levels is consistent with more stable cerebral blood flow during the challenging time of ES administration
Sin obras prominentes en esta página.
Do Different Amounts of Exogenous Surfactant Differently Influence Cerebrovascular Instability in a Consecutive Group of Preterm Babies? Preliminary Results from a Single-Center Experience
Our data obtained from the group with > 3 fractionated doses of ES seem to justify the preparation of a more robust study, as the combination of reduced NIRS variability and reduced tCO 2 maximum levels is consistent with more stable cerebral blood flow during the challenging time of ES administration
Second Attempt for Patent Ductus Arteriosus (PDA) Closure
Background : The diagnosis of hemodynamically significant patent ductus arteriosus (hsPDA) occurs in 55% of very low birth weight (VLBW) preterm infants. There is no agreement on the best approach to ensure a quick hsPDA closure. Drug treatment of hsPDA fails in approximately 20% of cases with an increasing risk of prolonged ventilation, BPD, and NEC, as well as the need for surgical duct ligation. This study aims to highlight the efficacy of ibu…
Anesthesia (2 obras) · Medicine (2 obras) · Pediatrics (2 obras) · Acetaminophen (1 obras) · Acidosis (1 obras) · Cardiovascular Conditions and Treatments (1 obras) · Cerebral blood flow (1 obras) · Chemistry (1 obras) · Congenital Heart Disease Studies (1 obras) · Ductus arteriosus (1 obras)